Results 141 to 150 of about 5,429 (239)
Long-term follow-up of memory impairment after third ventricle colloid cyst surgery. [PDF]
Zywczyk M +4 more
europepmc +1 more source
Biomaterial‐integrated electroporation establishes a programmable therapeutic interface that coordinates electric‐field modulation, transient or irreversible membrane permeabilization, cargo stabilization, and immune remodeling. This Review highlights how nanocarriers, hydrogels, and bioelectronic interfaces expand electroporation from conventional ...
Binbin Ji +13 more
wiley +1 more source
Colloid cyst of the third ventricle: a rare case of spontaneous regression. Illustrative case. [PDF]
Todorovic M +3 more
europepmc +1 more source
Colloid cyst curtailed: A case report of spontaneous colloid cyst regression. [PDF]
Cosgrove ME, Saadon J, Chesler DA.
europepmc +1 more source
Retrospective evaluation of endoscopic treatment in colloid cyst of the third ventricle. [PDF]
Stachura K +3 more
europepmc +1 more source
Uniform Microscale Thermoresponsive Liposomes for Controlled Release Above Body Temperature
Uniform thermoresponsive liposomes are generated using a scalable double‐emulsion microfluidic approach coupled with accelerated solvent extraction. The resulting liposomes remain stable at physiological temperature but undergo abrupt rupture and cargo release at 41°C–45°C, providing a versatile platform for thermally triggered controlled release in ...
S. Morteza Mousavi +6 more
wiley +1 more source
Parasitic colloid cyst: A diagnostic dilemma. [PDF]
Lewis AJ +3 more
europepmc +1 more source
Solitary Metastasis of Colon Adenocarcinoma Mimicking Colloid Cyst of the Third Ventricle. [PDF]
Hrushka JM +4 more
europepmc +1 more source
A multivalent bi‐specific nanoerythrosome (mBiNE@tPA) is developed as a “two‐birds‐one‐stone” platform that simultaneously exploits two principal thrombus components. By integrating erythrocyte membrane‐mediated homologous targeting with cRGD‐based active targeting to activated platelets, mBiNE@tPA achieves enhanced thrombus accumulation, triggered ...
Yu Huang +10 more
wiley +1 more source
Cancer nanovaccines have emerged as promising alternatives to conventional cancer vaccines, which have shown limited clinical efficacy. In particular, cell membrane nanoparticle‐based nanovaccines can offer high biocompatibility and immunogenicity while preserving tumor antigens, including antigen repertoires.
Munsik Kim, Ilkoo Noh
wiley +1 more source

